Estrógenos y péptido neurotensina en neoplasias de miometrio

Referencias bibliográficas

• Baird, D. D. and D. B. Dunson. Why is parity protective for uterine fibroids? Epidemiology 2003;14(2): 247-50.
• Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V. Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril. 2008 Nov;90(5):1878-85. Epub 2007 Dec 31.
• Benassayag C, Leroy MJ, Rigourd V, Robert B, Honoré JC, Mignot TM, Vacher-Lavenu MC, Chapron C, Ferré F. Estrogen receptors (ERalpha/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol. 1999 Jun;276(6 Pt 1):E1112-8.
• Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005 Apr;19(4):833-42. Epub 2005 Feb 3.
• Blake, R. E. Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc 2007;99(10): 1170-84.
• Brandon DD, Bethea CL, Strawn EY, Novy MJ, Burry KA, Harrington MS, Erickson TE, Warner C, Keenan EJ, Clinton GM. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 1993 Jul;169(1):78-85.
• Carraway RE, Hassan S. Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress. Regul Pept. 2007 Jun 7;141(1-3):140-53. Epub 2007 Jan 16.
• Chen GG, Zeng Q, Tse GM. Estrogen and its receptors in cancer. Med Res Rev. 2008 Nov;28(6):954-74.
• Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev. 2006 58(4):773-81.
• Elek J, Pinzon W, Park KH, Narayanan R. Relevant genomics of neurotensin receptor in cancer. Anticancer Res. 2000. 20(1A):53-8.
• Evans, P. and S. Brunsell. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007; 75(10): 1503-8.
• Evers BM. Neurotensin and growth of normal and neoplastic tissues. Peptides. 2006 Oct;27(10):2424-33.
• Flake, G. P., J. Andersen. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111(8): 1037-54.
• Gargett CE, Bucak K, Zaitseva M, Chu S, Taylor N, Fuller PJ, Rogers PA. Estrogen receptor-alpha and -beta expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Mol Hum Reprod. 2002 8(8):770-5.
• Gargett CE, Zaitseva M, Bucak K, Chu S, Fuller PJ, Rogers PA. 17Beta-estradiol upregulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and –beta. J Clin Endocrinol Metab. 2002. 87(9):4341-9.
• Giuntoli RL 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007 Nov;52(11):1001-10.
• Gui X, Guzman G, Dobner PR, Kadkol SS. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma. Peptides. 2008 Sep;29(9):1609-15. Epub 2008.
• Hall JM, Korach KS. Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens. J Biol Chem. 2002 Nov 15;277(46):44455-61.
• Hart R, Khalaf Y, Yeong CT, Seed P, Taylor A, Braude P. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod. 2001. 16(11):2411-7.
• Hyder SM, Stancel GM. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol. 1999 Jun;13(6):806-11.
• Indraccolo U, Luchetti G, Indraccolo SR. Malignant transformation of uterine leiomyomata. Eur J Gynaecol Oncol. 2008;29(5):543-4
• Ioffe YJ, Li AJ, Walsh CS, Karlan BY, Leuchter R, Forscher C, Cass I.. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles. Gynecol Oncol. 2009 Dec;115(3):466-71.
• Jakimiuk AJ, Bogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wróbel A, Haczyński J, Magoffin DA, Jakowicki JA. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril. 2004 Oct;82 Suppl 3:1244-9.
• Jongen V, Briët J, de Jong R, ten Hoor K, Boezen M, van der Zee A, Nijman H, Hollema H. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol. 2009 Mar;112(3):537- 42.
• Kovács KA, Oszter A, Göcze PM, Környei JL, Szabó I. Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium. Mol Hum Reprod. 2001 Nov;7(11):1085-91
• Markowska A, Rucinski M, Drews K, Malendowicz LK. Further studies on leptin and leptin receptor expression in myometrium and uterine myomas. Eur J Gynaecol Oncol. 2005;26(5):517-25.
• Markowska A, Rucinski M, Drews K, Malendowicz LK. Studies on leptin and leptin receptor gene expression in myometrium and uterine myomas of gnRH analogue-treated women. Eur J Gynaecol Oncol. 2006;27(4):379-84.
• Mylonas I, Jeschke U, Shabani N, Kuhn C, Kriegel S, Kupka MS, Friese K. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ERalpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res. 2005 May-Jun;25(3A):1679-86
• Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Anticancer Res. 2005 May-Jun;25(3A):1719-23
• Okolo, S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22(4): 571-88
• Parker, W. H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007;87(4): 725-36
• Reubi JC, Laissue JA, Waser B, Steffen DL, Hipkin RW, Schonbrunn A. . Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts.. J Clin Endocrinol Metab. 1999 Aug;84(8):2942-50.
• Roan CJ, Chuang JH, Hsu TY, Tsai HY, Pan LL, Cheng JT. . Estrogen receptor beta is not increasingly expressed in leiomyoma nodules which show no progressive enlargement in premenopausal women. J Formos Med Assoc. 2005 Dec;104(12):920-6.
• Sankaran, S. and I. T. Manyonda.. Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22(4): 655-76
• Seethalakshmi L, Mitra SP, Dobner PR, Menon M, Carraway RE.. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations.. Prostate. 1997 May 15;31(3):183-92.
• Sehgal I, Powers S, Huntley B, Powis G, Pittelkow M, Maihle NJ.. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4673-7.
• Shaaban AM, Speirs V.. The estrogen receptors alpha, beta, and beta cx. Clin Cancer Res. 2005 Nov 15;11(22):8222-3
• Singh AM, Konjengbam R, Devi SS, Devi NP. Leiomyosarcoma of uterus--a case report. J Indian Med Assoc. 2006 Mar;104(3):142, 144, 147
• Somaï S, Gompel A, Rostène W, Forgez P.. Neurotensin counteracts apoptosis in breast cancer cells.. Biochem Biophys Res Commun. 2002 Jul 12;295(2):482-8.
• Souazé F, Dupouy S, Viardot-Foucault V, Bruyneel E, Attoub S, Gespach C, Gompel A, Forgez P.. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.. Cancer Res. 2006 Jun 15;66(12):6243-9.
• Stovall DW, Van Voorhis BJ, Sparks AE, Adams LM, Syrop CH. Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation. Fertil Steril. 1998;Dec;70(6):1056-62
• Sung CO, Ahn G, Song SY, Choi YL, Bae DS.. Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors.. Int J Gynecol Pathol. 2009 Nov;28(6):529-34
• Taran FA, Weaver AL, Gostout BS, Stewart EA.. Understanding cellular leiomyomas: a case-control study. Am J Obstet Gynecol. 2010 Aug;203(2):109.e1-6.
• Taylor SE, Patel II, Singh PB, Nicholson CM, Stringfellow HF, Gopala Krishna RK, Matanhelia SS, Martin-Hirsch PL, Martin FL.. Elevated oestrogen receptor splice variant ERα∆5 expression in tumour-adjacent hormone-responsive tissue. Int J Environ Res Public Health. 2010 Nov;7(11):3871-89.
• Thomas RP, Hellmich MR, Townsend CM Jr, Evers BM.. Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.. Endocr Rev. 2003 Oct;24(5):571-99. Venables JP.. Aberrant and alternative splicing in cancer.. Cancer Res. 2004 Nov 1;64(21):7647-54.
• Walker, C. L. and E. A. Stewart. Uterine fibroids: the elephant in the room. Science 2005; 308(5728): 1589-92
• Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, Zhou X.. May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis. Med Oncol. 2011 Mar;28(1):42-50. Epub 2009 Dec 30.
• Wilkinson N, Rollason TP.. Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology. 2001 Oct;39(4):331-41.
• Xu Q, Takekida S, Ohara N, Chen W, Sitruk-Ware R, Johansson ED, Maruo T. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphateribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab. 2005 Feb;90(2):953-61.
• Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, Ishikawa H, Xue Q, Reierstad S, Innes J, Thung S, Kim JJ, Xu E, Bulun SE.. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab. 2007 Nov;92(11):4459-66.